Novo Nordisk AS (HAM:NOVA)
€ 41.8 -0.20 (-0.48%) Market Cap: 185.04 Bil Enterprise Value: 201.74 Bil PE Ratio: 11.60 PB Ratio: 6.95 GF Score: 81/100

Novo Nordisk A/S Virtual R&D Investor Presentation Transcript

Jun 19, 2020 / 01:00PM GMT
Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board

/- -

Ladies and gentlemen, welcome to the Novo Nordisk R&D Investor Event. We've been looking forward to this event. As you know that over the past number of weeks we've had some really exciting pipeline readouts. So today, we have the opportunity to go into greater details on the trial readouts we just had.

With me today, I have our Chief Science Officer, Mads Krogsgaard Thomsen, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot